Showing 5,841 - 5,860 results of 31,327 for search '(( 50 ((teer decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( a step decrease ))', query time: 1.15s Refine Results
  1. 5841
  2. 5842
  3. 5843

    Structure-function correlation of the central retina in a patient with X-linked retinoschisis (upper panels) and a patient with Usher syndrome 2A (lower panels). by Peter Charbel Issa (241475)

    Published 2010
    “…Only the most distinct alterations result in a relative scotoma (10 dB decreased light intensity compared to the brightest stimulus). …”
  4. 5844
  5. 5845
  6. 5846

    Proposed Dyrk1A functions in regulating synaptic vesicle endocytosis. by Noriko Murakami (171144)

    Published 2012
    “…<p>Dyrk1A phosphorylated AP180 in cytosol. The phosphorylated AP180 may decrease its binding affinity to the AP2 complex; we hypothesize here that the decrease in such binding affinity would reduce recruitment of clathrin at the <i>nucleation</i> and <i>invagination</i> sites. …”
  7. 5847

    Lack of HP1a or POF shifts the enrichment pattern of RNA pol II on chromosome 4. by Nicole C. Riddle (134424)

    Published 2012
    “…In both HP1a and POF mutants, the RNA pol II enrichment decreases significantly only in the gene body. …”
  8. 5848

    Zinc exposure attenuates NR2A clusters and currents. by Jia Zhu (135506)

    Published 2012
    “…Both the number and mean intensity of NR2A clusters significantly decreased after zinc treatment. …”
  9. 5849

    Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma by Yueying Zhou (450705)

    Published 2015
    “…On the other hand, knockdown of PODXL significantly decreased the Bmi1 expression level and cisplatin IC50 and increased cisplatin-induced cell apoptosis, which was completely reversed by overexpression of Bmi1. …”
  10. 5850
  11. 5851
  12. 5852

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  13. 5853

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  14. 5854

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  15. 5855

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  16. 5856

    CsrA modulates the expression of a thiamine pyrophosphate (TPP) riboswitch element. by Tobias Sahr (3756775)

    Published 2017
    “…<b>B</b>) EMSA with 200nM of biotinylated thi-element (TPP) RNA and purified CsrA: Lane 1: no CsrA, lane 2: 1.0 μM CsrA, lane 3: 2.0 μM CsrA, lane 4: 5.0 μM CsrA, lane 5: 5.0 μM CsrA + 2.0 μM unlabeled RsmZ. …”
  17. 5857
  18. 5858

    Amiselimod (MT-1303), a novel sphingosine 1-phosphate receptor-1 functional antagonist, inhibits progress of chronic colitis induced by transfer of CD4<sup>+</sup>CD45RB<sup>high</... by Kyoko Shimano (2304151)

    Published 2019
    “…MT-1303 phosphate (MT-1303-P), an active metabolite of MT-1303, exhibits S1P<sub>1</sub> receptor agonism at a lower EC<sub>50</sub> value than other S1P<sub>1</sub> receptor modulators currently being developed. …”
  19. 5859
  20. 5860